Narita Koichi

ナリタコウイチ | Narita Koichi

Affiliation and department：

Research field (1)： Pharmaceuticals - chemistry and drug development

Research keywords (3)：全合成 , 天然物合成 , 有機合成化学

Research theme for competitive and other funds (6)：

2021 - 2026 Chemical investigation of traditional medicines for controlling infectious diseases, including zoonosis, oriented to eliminate pathogens and vectors
2020 - 2023 Development and application of a convergent synthetic method for maleimide natural products
2021 - 2022 安全性の高いトリパノソーマ症新規治療薬の開発を目指したモンゴル国薬用植物由来2,5-ジフェニルオキサゾール誘導体の合成と活性評価
2020 - 2021 モンゴル国薬用植物由来 2,5-ジフェニルオキサゾールをシード化合物とした安全性の高い新規トリパノソーマ症治療薬の開発
2015 - 2019 Synthetic Studies on Biologically Active Natural Products Aimed at Drug Discovery of Novel Molecular Target Anticancer Agents

Show all

Papers (38)：

Koichi Narita, Shotaro Yoshida, Hiroka Satoh, Kazuhiro Watanabe, Yuichi Yoshimura. Synthetic route for optically active tetracyclic hexahydrobenzofurobenzopyran skeleton of bisabosquals. Tetrahedron. 2022. 119. 132871-132871
Takaaki Kamishima, Masato Suzuki, Koichi Narita, Yoshitaka Koseki, Toshiyuki Nonaka, Hirotaka Nakatsuji, Hideo Hattori, Hitoshi Kasai. Total synthesis and antimicrobial evaluation of (+)-hygrophorone B12 and its analogues. Scientific reports. 2022. 12. 1. 7471-7471
成田紘一, 菅沼啓輔, 村田敏拓, 近藤龍太郎, 佐藤廣河, 渡邉一弘, 佐々木健郎, 井上昇, 吉村祐一. 天然由来の2,5-ジフェニルオキサゾール誘導体の合成と抗トリパノソーマ活性評価. 日本薬学会年会要旨集. 2022. 142年会. 28PO9-15
Koichi Narita. [Synthetic Study on Bicyclic Depsipeptides Containing an Intramolecular Disulfide Bond]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 2022. 142. 9. 917-926
Koichi Narita, Keisuke Suganuma, Toshihiro Murata, Ryutaro Kondo, Hiroka Satoh, Kazuhiro Watanabe, Kenroh Sasaki, Noboru Inoue, Yuichi Yoshimura. Synthesis and evaluation of trypanocidal activity of derivatives of naturally occurring 2,5-diphenyloxazoles. Bioorganic & medicinal chemistry. 2021. 42. 116253-116253

ｍore...

MISC (27)：

佐藤廣河, 保坂猛成, 成田紘一, 渡邉一弘, 吉村祐一. Total synthesis of ferruginene A and B using the Schenk-ene reaction. 日本薬学会年会要旨集(Web). 2022. 142nd
佐藤廣河, 成田紘一, 吉村祐一, 渡邉一弘. Synthetic study on anti-cancer agent 9-deoxyxenialactol C. 日本薬学会年会要旨集(Web). 2021. 141st
佐藤廣河, 成田紘一, 吉村祐一, 渡邉一弘. 抗がん活性を有する9-デオキシキセニアラクトールCの合成研究. 日本薬学会東北支部大会講演要旨集. 2020. 59th
吉田昌太郎, 成田紘一, 佐藤廣河, 渡邉一弘, 吉村祐一. Synthetic study on squalene synthase inhibitor bisabosqual A. 日本薬学会年会要旨集(CD-ROM). 2020. 140th
佐藤廣河, 成田紘一, 吉村祐一, 渡邉一弘. Synthetic studies on anti-cancer agent 9-deoxyxenialactol C. 日本薬学会年会要旨集(CD-ROM). 2020. 140th

ｍore...

Patents (3)：

トリパノソーマ症の治療薬及び予防薬
Liphagal analog and multi-targeted kinase inhibitor containing liphagal or its analog
Synthetic intermediate of depsipeptide, and method for the preparation thereof

Education (2)：

Professional career (1)：

Work history (4)：

2022/04 - 現在 Tohoku Medical and Pharmaceutical University Faculty of Pharmaceutical Sciences
2016/04 - 2022/03 Tohoku Medical and Pharmaceutical University Faculty of Pharmaceutical Sciences
2015/04 - 2016/03 東北薬科大学薬学部助教
2010/04 - 2015/03 東北薬科大学薬学部助手

Awards (1)：

Association Membership(s) (3)：

THE JAPANESE CANCER ASSOCIATION , THE JAPANESE ASSOCIATION FOR MOLECULAR TARGET THERAPY OF CANCER , THE PHARMACEUTICAL SOCIETY OF JAPAN

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page